Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[bentleyt]

BlueChip$.....From The Super 10K Page 11....."Based on the preliminary insights Gene Biotherapeutics research is focused on the design of an observational clinical study to evaluate if Covid -19 may exacerbate microvascular damage and perfusion impairment in patients with pre existing coronary artery disease"......Basically They Are Evaluating Generx's Benefit For Covid 19 Heart Compromised Patients....GENERX Is Certainly A Candidate For CTAP.....Coronavirus Treatment Acceleration Program....IMHO The Company Is Doing This!!!!!